COPI | Purpose | Plan | Viability | Propagation | Culture Techniques
Crown Organogenesis Protocols Inc. (COPI) is a biotechnology-driven focused on the research, development, and commercialization of plant tissue culture and organogenesis protocols for high-value tropical and perfumery plantation crops.
It is dedicated to the development and advancement of organogenesis protocols for the efficient propagation of high-value perfumery crops, ensuring sustainable and high-quality plant production for the fragrance industry.
1. Biotech R&D Powerhouse
- Clonal propagation through organogenesis and somatic embryogenesis
- Elite mother plant development and conservation
- Mass micropropagation for scalable production of disease-free, uniform, and high-resin-yielding planting materials
2. Strategic Impact on Agarwood Industry
- Develops in vitro propagated Aquilaria malaccensis trees for plantation deployment under CAPI and inoculation under CMBI.
- Reduces pressure on wild populations and supports CITES compliance
- Accelerates supply of plantation-ready seedlings with known genetic and resin induction responsiveness
3. Revenue Streams
- Sale of tissue-cultured seedlings to Crown subsidiaries and third-party growers
- Technology licensing of proprietary organogenesis protocols
- Joint ventures with academic, governmental, and private sector biotech partners
- Custom propagation services for rare and indigenous Philippine plant species
4. Facilities and Infrastructure
- Operates modular tissue culture labs (e.g., 4m x 8m units) with scalable production lines
- Future expansion includes a Genomic Screening & DNA Barcoding Unit for varietal authentication
5. Investor Value Proposition
- Access to biotech IP in high-demand forestry and perfumery crops
- Core to vertical integration of Crown Agri Group’s agarwood supply chain
- High barrier to entry biotech space with scalable commercial applications
Terms and Conditions:
- Target of Incorporation: 2025
- Main Laboratory: Mendez, Cavite (Region 4A).
- Brand Identity: “The Science of Regenerative Growth”
- Share Capital Timeline: Will start accepting Share Capital Contribution from June 1 until August 31, 2025 on a first come, first served basis.
- Payment Method: Please issue Manager’s Check/Cashiers’ Check payable to Crown Organogenesis Protocols Inc. together with your Tax Identification Number (TIN) Card and Identification Documents (ID).
- Make yourself available in signing off the Securities and Exchange Commission (SEC) incorporation documents.
Future Expansion Project: Micropropagation laboratories expansion on strategic regions to meet the demand on a quality planting materials.
Stock Ownership and Distribution
